Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Non-cash Items: 2023-2025

Historic Non-cash Items for Zenas BioPharma (ZBIO) over the last 1 years, with Sep 2025 value amounting to $2.8 million.

  • Zenas BioPharma's Non-cash Items rose 178.48% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 178.48%. This contributed to the annual value of $1.3 million for FY2024, which is 83.99% down from last year.
  • Latest data reveals that Zenas BioPharma reported Non-cash Items of $2.8 million as of Q3 2025, which was up 73.49% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Zenas BioPharma's Non-cash Items ranged from a high of $8.1 million in Q4 2023 and a low of $1.0 million during Q3 2024.
  • Moreover, its 3-year median value for Non-cash Items was $1.5 million (2025), whereas its average is $2.7 million.
  • Per our database at Business Quant, Zenas BioPharma's Non-cash Items slumped by 83.99% in 2024 and then spiked by 178.48% in 2025.
  • Zenas BioPharma's Non-cash Items (Quarterly) stood at $8.1 million in 2023, then plummeted by 83.99% to $1.3 million in 2024, then surged by 178.48% to $2.8 million in 2025.
  • Its Non-cash Items was $2.8 million in Q3 2025, compared to $1.6 million in Q2 2025 and $1.4 million in Q1 2025.